Ulthera Revenue and Competitors
Estimated Revenue & Valuation
- Ulthera's estimated annual revenue is currently $20.6M per year.
- Ulthera's estimated revenue per employee is $251,000
- Ulthera's total funding is $39.7M.
Employee Data
- Ulthera has 82 Employees.
- Ulthera grew their employee count by 0% last year.
Ulthera's People
Name | Title | Email/Phone |
---|---|---|
1 | Manager, Practice Development Specialist | Reveal Email/Phone |
2 | Global Marketing Coordinator | Reveal Email/Phone |
3 | Principal Engineer | Reveal Email/Phone |
4 | National Market Development Specialist | Reveal Email/Phone |
5 | Principal Project Engineer | Reveal Email/Phone |
6 | Manufacturing Engineer | Reveal Email/Phone |
Ulthera Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $13.8M | 55 | 49% | N/A | N/A |
#2 | $9.8M | 39 | 0% | N/A | N/A |
#3 | $0.5M | 4 | 0% | N/A | N/A |
#4 | $20.3M | 81 | 65% | N/A | N/A |
#5 | $10.8M | 43 | 0% | N/A | N/A |
#6 | $28.1M | 112 | -3% | $83.2M | N/A |
#7 | $6.5M | 26 | 0% | N/A | N/A |
#8 | $8M | 19 | 0% | N/A | N/A |
#9 | $11M | 57 | 6% | N/A | N/A |
#10 | $12M | 48 | 7% | N/A | N/A |
What Is Ulthera?
Ulthera's therapeutic ultrasound platform is ground-breaking for cosmetic dermatology today. "The cosmetics market has been expanding very rapidly over the last few years and we believe we have identified the right team to lead the next phase of innovation in this space. Ulthera's founders have a long history of working together and developing both diagnostic and therapeutic ultrasound technologies. We expect that patients will be very receptive to their latest non-invasive microablation technology. Thought leading dermatologists and plastic surgeons are very much in support of the company and team," added Paul Badawi, 3i director and Ulthera board member.
keywords:N/A$39.7M
Total Funding
82
Number of Employees
$20.6M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Ulthera News
Syneron Candela, Beijing KES Biology, LPG, Venus Concept, Ulthera, Zimmer Aesthetics, Pollogen, Home Skinovations, Cynosure, Solta Medical, Syneron Candela.
... System Market Size, Scope And Outlook | Allergen, Mentor, Galderma, Valeant, Merz, Syneron, Zetiq, Ulthera, Cynosure, Solta/Valeant.
Act now for a lifting and tightening of the skin with Ultherapy® a non-invasive treatment for the face, neck and décolletage...
Ulthera, Inc., a Mesa, Ariz.-based developer of a ultrasound device approved by the FDA for aesthetics, raised $10.5m in Series C venture funding. The round was led by New Enterprise Associates (NEA), with participation from funds managed by Apposite Capital LLP. As also stated by President an ...
TODAY’S HEADLINES: Ulthera receives $23M for cosmetic ultrasound devices (release) Senexis raises £2.9M for Alzheimer’s drugs (PDF release) Elixir Pharma postpones IPO (IPO Home) Cancer Therapeutics names Randall Riggs as CEO (release) Ulthera receives $23M for cosmetic ultrasound devices — ...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $16.7M | 82 | 4% | N/A |
#2 | $20.5M | 82 | 5% | N/A |
#3 | $8.2M | 82 | -1% | N/A |
#4 | $25.3M | 82 | 5% | N/A |
#5 | $22.4M | 83 | 17% | N/A |